
Purdue Pharma, the manufacturer of OxyContin, is navigating a new path to resolve thousands of lawsuits related to the impact of opioids after the U.S. Supreme Court rejected their previous settlement agreement. The lawsuits involve state, local, and tribal governments, as well as individual victims seeking justice and financial compensation.